SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending following a massive fiscal quarter earnings beat, where the company significantly exceeded expectations across both revenue and EPS while issuing a major upward revision to its future guidance. The community is sharply divided, with bulls pointing to the explosive AI-driven memory supercycle as a justification for further gains, while vocal bears argue the stock is overextended and susceptible to a broader market correction.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is experiencing extreme price volatility and intense retail attention following its recent IPO, with the community actively debating whether its battle-tested drone software justifies the current valuation. Investors are intensely focused on the stock's potential for institutional contracts and multi-day momentum, with many monitoring psychological resistance levels while attempting to capitalize on what they perceive as a crowded short-squeeze setup.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is surging as investors bet on the company's ability to capitalize on soaring global LNG prices and supply shortages triggered by the blockade of the Strait of Hormuz and the shutdown of major Qatari facilities. The community is heavily focused on the company's significant exposure to the spot market, with many bulls arguing that recent geopolitical instability makes the stock a must-own hedge for long-term energy security.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is facing heavy selling pressure as retail investors sour on the stock's performance and concerns mount regarding the broader economic impact of Middle Eastern conflicts, with community discussion intensely focused on skepticism toward management and the company's long-term viability. Many traders are actively debating the stock's connection to Trumps political decisions, including trade policies and military engagements, while bearish sentiment dominates due to dilution concerns and lack of fundamental growth.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing extreme volatility and intense community debate as investors speculate on whether the stock's parabolic climb is a sustainable result of the AI memory supercycle or an overextended bubble primed for a sharp reversal. The conversation is currently dominated by conflicting views on the stock's valuation, with many traders closely watching the upcoming earnings report from Micron as a potential catalyst for either further gains or a significant correction.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is trending as investors weigh the significant impact of geopolitical conflicts, particularly the disruption of major LNG facilities and threats to the Strait of Hormuz, against broader concerns about record-high natural gas production and storage levels. Community discussion is heavily divided between bullish sentiment fueled by fears of long-term supply constraints and bearish warnings from traders highlighting the extreme volatility, historical decay, and the role of speculative news in driving price swings.

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate is experiencing intense volatility and volume as investors weigh recent manufacturing inquiries from the FDA against the bullish thesis surrounding a pending US patent approval and the upcoming PDUFA date. While some in the community view the current price drop as a short-induced overreaction and an opportunity to accumulate, others are expressing concern over the potential for timeline extensions and the company's financial burn rate.

Palladyne AI Corp. engages in the design, development, and manufacture of industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Its products include Palldyne IQ and Palladyne Pilot. The company was founded by Fraser M. Smith and Benjamin G. Wolff in 2015 and is headquartered in Salt Lake City, UT.

Palladyne AI Corp.

Palladyne AI is seeing significant market activity fueled by strong earnings, reaffirmed multi-hundred percent revenue growth guidance, and successful defense contract wins for missile propulsion and autonomous swarm technology. While the stock experiences high volatility, the community remains intensely divided between retail investors betting on a short squeeze due to high short interest and long-term supporters focused on the companys strategic pivot into integrated defense manufacturing.

DLocal Ltd. engages in the business of simplifying and redefining online payments experience. It focuses on processing payment transactions which enables merchants to get paid from customers and to make payments to customers in emerging markets. The company was founded by Andrés Bzurovski Bay and Sergio Enrique Fogel Kaplan in 2016 and is headquartered in Montevideo, Uruguay.

DLocal Limited - Ordinary Shares Class A

DLocal Limited

DLocal Limited is seeing significant momentum following a robust earnings report that showcased strong revenue growth, high payment volume records, and a commitment to shareholder returns through share buybacks and dividends. The community is actively debating the company's valuation against its rapid growth in emerging markets, with many investors focusing on the stock's potential for a short squeeze given the high short interest and its strategic position as an asset-light financial infrastructure provider.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant is trending as the community debates its long-term utility in bank-led projects like the UK's tokenized deposit pilot versus its lack of recent price momentum. Investors are actively discussing the potential for a supply-driven breakout as institutional adoption grows, while others express frustration over the token's persistent price consolidation compared to the broader market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HC Wainwright Issues Negative Forecast for CRBP Earnings

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) - Research analysts at HC Wainwright dropped their Q1 2026 earnings estimates for shares of Corbus Pharmaceuticals in a research...

How Much Upside is Left in Corbus Pharmaceuticals (CRBP)? Wall Street Analysts Think 318.33%

The mean of analysts' price targets for Corbus Pharmaceuticals (CRBP) points to a 318.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Research Analysts Offer Predictions for CRBP FY2030 Earnings

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) - Equities researchers at HC Wainwright issued their FY2030 earnings per share (EPS) estimates for shares of Corbus Pharmaceuticals...

Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Price Expected to Rise, Oppenheimer Analyst Says

Oppenheimer boosted their price target on shares of Corbus Pharmaceuticals from $53.00 to $57.00 and gave the company an "outperform" rating in a research report on Tuesday...

Corbus Pharmaceuticals (NASDAQ:CRBP) Releases Quarterly Earnings Results

Corbus Pharmaceuticals (NASDAQ:CRBP - Get Free Report) announced its quarterly earnings results on Monday. The biopharmaceutical company reported ($1.25) earnings per share for the quarter, beating...

Corbus Pharmaceuticals (CRBP) to Release Quarterly Earnings on Tuesday

Corbus Pharmaceuticals (NASDAQ:CRBP) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 10. (View Earnings Report at...

Corbus Pharmaceuticals Touts Catalyst-Rich 2026 With CRB-701 and CRB-913 Data Readouts Ahead

Corbus Pharmaceuticals (NASDAQ:CRBP) outlined a catalyst-rich 2026 at Oppenheimer's 36th Annual Healthcare Conference, with Chief Executive Officer Yuval Cohen highlighting upcoming mid-year and...

Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Rating Upgraded by Jefferies Financial Group

Jefferies Financial Group raised Corbus Pharmaceuticals to a "strong-buy" rating in a research note on Wednesday...

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eleven research firms that are currently covering the firm...

Corbus Pharmaceuticals (NASDAQ:CRBP) COO Ian Hodgson Sells 2,415 Shares

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Get Free Report) COO Ian Hodgson sold 2,415 shares of the business's stock in a transaction that occurred on Tuesday, February 3rd. The stock was...

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.

Current Price	$9.05
Prev Close	$9.63
Open	$9.53
Dividend Yield	0.00%
50-Day Moving Average	$8.36
Beta	1.19
Avg. Volume	160,039.73
PE Ratio	-1.61

52-Week High	$20.56
52-Week Low	$4.64
Market Capitalization	$170.8M
EPS (Annual)	-$5.90
Price to Book	1.15
Revenue Per Employee	$0.00

CRBP
Corbus Pharmaceuticals Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CRBP News

CRBPCorbus Pharmaceuticals Holdings Inc